Diabetic Peripheral Neuropathy (DPN) Completed Phase 2 Trials for Gabapentin (DB00996)

Also known as: Peripheral Diabetic Neuropathy / Diabetic Peripheral Neuropathy / Diabetic Neuropathy Peripheral / Diabetic neuropathy / Diabetic Neuropathies

IndicationStatusPhase
DBCOND0049986 (Diabetic Peripheral Neuropathy (DPN))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00712439Safety and Efficacy of Gabapentin in Diabetic Peripheral NeuropathyTreatment